Clinical Scorecard: Creation and assessment of a radiopathomics model for forecasting liver metastases in colorectal cancer patients

At a Glance

Key Highlights

• Liver metastases occur in at least 50% of colorectal cancer patients postoperatively, significantly impacting mortality.
• Traditional TNM staging lacks sufficient accuracy for predicting liver metastases; radiomics offers quantitative imaging biomarkers.
• A combined model using CT radiomics and clinical features improves prediction of postoperative liver metastases.

Guideline-Based Recommendations

Diagnosis

• Use pathological examination as the gold standard for liver metastases diagnosis post-surgery.
• Employ preoperative abdominal and pelvic CT scans with standardized imaging protocols for radiomics feature extraction.
• Apply quantitative radiomics analysis following International Biomarker Standardization Initiative guidelines.

Management

• Consider preoperative treatment strategies to reduce metastasis risk based on accurate staging and risk prediction.
• Use combined radiomics and clinical models to guide personalized treatment planning and patient selection.

Monitoring & Follow-up

• Regular follow-up imaging and clinical data collection to monitor for liver metastases development postoperatively.

Risks

• Invasiveness and impracticality of frequent pathological examinations limit their use for ongoing monitoring.
• Variability in clinician experience affects the reliability of conventional CT interpretation without radiomics.

Patient & Prescribing Data

Colorectal cancer patients undergoing radical surgery with available preoperative CT and clinical data

Radiopathomics models enable early identification of high-risk patients who may benefit from intensified preoperative or adjuvant therapies.

Clinical Best Practices

• Ensure high-quality, standardized CT imaging acquisition and preprocessing for reproducible radiomics feature extraction.
• Use multidisciplinary review of imaging and clinical data to resolve discrepancies in tumor delineation.
• Apply rigorous feature selection combining statistical tests and L1 regularization to optimize predictive model performance.
• Integrate radiomics scores with clinical variables using score-level fusion methods to enhance prediction accuracy.
• Adopt models validated on retrospective cohorts with comprehensive clinical and imaging datasets.

References

• Colorectal cancer incidence and mortality statistics
• International Biomarker Standardization Initiative guidelines
• 3D Slicer software for tumor segmentation